Fennec Pharmaceuticals (FENC) Operating Expenses (2010 - 2026)
Fennec Pharmaceuticals' (FENC) quarterly Operating Expenses came in at $16.3 million in Q4 2025, up 84.34% YoY from $8.9 million in Q4 2024, and up 29.09% on a QoQ basis from $12.7 million in Q3 2025.
Fennec Pharmaceuticals (FENC) Operating Expenses (2010 - 2026) Analysis & Trends
Fennec Pharmaceuticals (FENC) has 16 years of Operating Expenses data on file, last reported at $16.3 million in Q4 2025.
- Quarterly Operating Expenses rose 84.34% year-over-year to $16.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $50.9 million (up 13.24% YoY) and the FY2025 annual result came in at $50.9 million, up 13.24% from the prior year.
- Operating Expenses rose to $16.3 million in Q4 2025, from $12.7 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $16.3 million in Q4 2025 to a low of -$5.0 million in Q2 2022.
- A 5-year average of $8.1 million and a median of $7.9 million in 2022 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2022 — Operating Expenses sank 227.78% — and 2023, when it jumped 259.53%.
- Tracing FENC's Operating Expenses over 5 years: stood at $4.2 million in 2021, then soared by 80.27% to $7.6 million in 2022, then surged by 52.33% to $11.6 million in 2023, then slipped by 23.32% to $8.9 million in 2024, then surged by 84.34% to $16.3 million in 2025.
- The last three Operating Expenses figures came in at $16.3 million (Q4 2025), $12.7 million (Q3 2025), and $12.4 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Fennec Pharmaceuticals | 410.60 Mn | 369.35 Mn | 17.15 Mn | 16.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.14 Mn |
| Dec 31, 2025 | 16.33 Mn |
| Sep 30, 2025 | 12.65 Mn |
| Jun 30, 2025 | 12.38 Mn |
| Mar 31, 2025 | 9.56 Mn |
| Dec 31, 2024 | 8.86 Mn |
| Sep 30, 2024 | 12.18 Mn |
| Jun 30, 2024 | 12.30 Mn |
| Mar 31, 2024 | 11.63 Mn |
| Dec 31, 2023 | 11.55 Mn |
| Sep 30, 2023 | 7.53 Mn |
| Jun 30, 2023 | 7.99 Mn |
| Mar 31, 2023 | 6.95 Mn |
| Dec 31, 2022 | 7.58 Mn |
| Sep 30, 2022 | 7.90 Mn |
| Jun 30, 2022 | -5.01 Mn |
| Mar 31, 2022 | 3.55 Mn |
| Dec 31, 2021 | 4.21 Mn |
| Sep 30, 2021 | 4.17 Mn |
| Jun 30, 2021 | 3.92 Mn |